journal article·2025-04

Pillararene based supramolecular nanoplatform for endoplasmic reticulum-targeting type I photodynamic and NO gas therapy

Shaoqi Xie, Chang Liu, Yue Cao, Jiachen Xia, Bing Lu

Science China Materials· Volume 68· Issue 4
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin, 2024, 74: 12–4910.3322/caac.21820 ↗
2. Overchuk M, Weersink RA, Wilson BC, et al. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine. ACS Nano, 2023, 17: 7979–800310.1021/acsnano.3c00891 ↗
3. Xie Z, Fan T, An J, et al. Emerging combination strategies with phototherapy in cancer nanomedicine. Chem Soc Rev, 2020, 49: 8065–808710.1039/D0CS00215A ↗
4. Zhao X, Liu J, Fan J, et al. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application. Chem Soc Rev, 2021, 50: 4185–421910.1039/D0CS00173B ↗
5. Yang Y, Huang Z, Li LL. Advanced nitric oxide donors: chemical structure of NO drugs, NO nanomedicines and biomedical applications. Nanoscale, 2021, 13: 444–45910.1039/D0NR07484E ↗
6. Liu S, Li G, Ma D. Controllable nitric oxide-delivering platforms for biomedical applications. Adv Ther, 2022, 5: 210022710.1002/adtp.202100227 ↗
7. Huang W, Zhang J, Luo L, et al. Nitric oxide and tumors: from smallmolecule donor to combination therapy. ACS BioMater Sci Eng, 2023, 9: 139–15210.1021/acsbiomaterials.2c01247 ↗
8. Li X, Li X, Park S, et al. Photodynamic and photothermal therapy via human serum albumin delivery. Coord Chem Rev, 2024, 520: 21614210.1016/j.ccr.2024.216142 ↗
9. Yuan X, Zhou JL, Yuan L, et al. Phototherapy: progress, challenges, and opportunities. Sci China Chem, 2024, 68: 826–886510.1007/s11426-024-2411-7 ↗
10. Grayton QE, Phan TT, Kussatz CC, et al. Hyaluronic acid-coated silica nanoparticles for targeted delivery of nitric oxide to cancer cells. ACS Appl Bio Mater, 2024, 7: 3796–380910.1021/acsabm.4c00171 ↗
11. Kim N, Lee S, Park H, et al. Development of an intracellular nitric oxide-donating cell-penetrating polypeptide as an immunogenic cell death inducer. ACS Appl Bio Mater, 2024, 7: 6791–679910.1021/acsabm.4c00941 ↗
12. Wang Y, Huang X, Tang Y, et al. A light-induced nitric oxide controllable release nano-platform based on diketopyrrolopyrrole derivatives for pH-responsive photodynamic/photothermal synergistic cancer therapy. Chem Sci, 2018, 9: 8103–810910.1039/C8SC03386B ↗
13. Xu C, Pu K. Second near-infrared photothermal materials for combinational nanotheranostics. Chem Soc Rev, 2021, 50: 1111–113710.1039/D0CS00664E ↗
14. Sun J, Cai X, Wang C, et al. Cascade reactions by nitric oxide and hydrogen radical for anti-hypoxia photodynamic therapy using an activatable photosensitizer. J Am Chem Soc, 2021, 143: 868–87810.1021/jacs.0c10517 ↗
15. Li X, Kwon N, Guo T, et al. Innovative strategies for hypoxic-tumor photodynamic therapy. Angew Chem Int Ed, 2018, 57: 11522–1153110.1002/anie.201805138 ↗
16. Fan W, Huang P, Chen X. Overcoming the Achilles’ heel of photodynamic therapy. Chem Soc Rev, 2016, 45: 6488–651910.1039/C6CS00616G ↗
17. Wan Y, Fu LH, Li C, et al. Conquering the hypoxia limitation for photodynamic therapy. Adv Mater, 2021, 33: 210397810.1002/adma.202103978 ↗
18. Teng KX, Niu LY, Yang QZ. Supramolecular photosensitizer enables oxygen-independent generation of hydroxyl radicals for photodynamic therapy. J Am Chem Soc, 2023, 145: 4081–408710.1021/jacs.2c11868 ↗
19. Teng KX, Niu LY, Yang QZ. A host–guest strategy for converting the photodynamic agents from a singlet oxygen generator to a superoxide radical generator. Chem Sci, 2022, 13: 5951–595610.1039/D2SC01469F ↗
20. Teng K, Zhang D, Liu B, et al. Photo-induced disproportionation-mediated photodynamic therapy: simultaneous oxidation of tetrahydrobiopterin and generation of superoxide radicals. Angew Chem Int Ed, 2024, 63: 20231878310.1002/anie.202318783 ↗
21. Wang Y, Yang T, He Q. Strategies for engineering advanced nanomedicines for gas therapy of cancer. Natl Sci Rev, 2020, 7: 1485–151210.1093/nsr/nwaa034 ↗
22. Gao P, Pan W, Li N, et al. Boosting cancer therapy with organelletargeted nanomaterials. ACS Appl Mater Interfaces, 2019, 11: 26529–2655810.1021/acsami.9b01370 ↗
23. Xia J, Quan H, Huang Y, et al. Side chain programming synchronously enhances the photothermal conversion efficiency and photodynamic activity of A–D–A photosensitizers. ACS Macro Lett, 2024, 13: 489–49410.1021/acsmacrolett.4c00031 ↗
24. Xiao H, Li P, Hu X, et al. Simultaneous fluorescence imaging of hydrogen peroxide in mitochondria and endoplasmic reticulum during apoptosis. Chem Sci, 2016, 7: 6153–615910.1039/C6SC01793B ↗
25. Kand D, Pizarro L, Angel I, et al. Organelle-targeted BODIPY photocages: visible-light-mediated subcellular photorelease. Angew Chem Int Ed, 2019, 58: 4659–466310.1002/anie.201900850 ↗
26. Wang W, Zhang Y, Wang Z, et al. A native drug-free macromolecular therapeutic to trigger mutual reinforcing of endoplasmic reticulum stress and mitochondrial dysfunction for cancer treatment. ACS Nano, 2023, 17: 11023–1103810.1021/acsnano.3c03450 ↗
27. Zeng S, Wang Y, Chen C, et al. An ER-targeted, viscosity-sensitive hemicyanine dye for the diagnosis of nonalcoholic fatty liver and photodynamic cancer therapy by activating pyroptosis pathway. Angew Chem Int Ed, 2024, 63: 20231648710.1002/anie.202316487 ↗
28. Mehmood AH, Ullah F, Dong B, et al. Reaction-based small-molecule fluorescent probes for endoplasmic reticulum- and mitochondria-targeted biosensing and bioimaging. Sci China Mater, 2024, 67: 3491–353010.1007/s40843-024-3097-4 ↗
29. Zhang H, Liu Z, Zhao Y. Pillararene-based self-assembled amphiphiles. Chem Soc Rev, 2018, 47: 5491–552810.1039/C8CS00037A ↗
30. Ogoshi T, Kakuta T, Yamagishi T-. Applications of pillar[n]arene-based supramolecular assemblies. Angew Chem Int Ed, 2018, 58: 2197–220610.1002/anie.201805884 ↗
31. Wang C, Li H, Dong J, et al. Pillararene-based supramolecular vesicles for stimuli-responsive drug delivery. Chem Eur J, 2022, 28: e20220205010.1002/chem.202202050 ↗
32. Tang R, Ye Y, Zhu S, et al. Pillar[6]arenes: from preparation, host-guest property to self-assembly and applications. Chin Chem Lett, 2023, 34: 10773410.1016/j.cclet.2022.08.014 ↗
33. Zhou J, Rao L, Yu G, et al. Supramolecular cancer nanotheranostics. Chem Soc Rev, 2021, 50: 2839–289110.1039/D0CS00011F ↗
34. Li X, Shen M, Yang J, et al. Pillararene-based stimuli-responsive supramolecular delivery systems for cancer therapy. Adv Mater, 2024, 36: 231331710.1002/adma.202313317 ↗
35. Zhu H, Li Q, Khalil-Cruz LE, et al. Pillararene-based supramolecular systems for theranostics and bioapplications. Sci China Chem, 2021, 64: 688–70010.1007/s11426-020-9932-9 ↗
36. Feng W, Jin M, Yang K, et al. Supramolecular delivery systems based on pillararenes. Chem Commun, 2018, 54: 13626–1364010.1039/C8CC08252A ↗
37. Song YH, Bian Q, Wang F, et al. Water-soluble stimuli-responsive supramolecular nanoagrochemicals based on macrocycle compounds. Coord Chem Rev, 2025, 524: 21629910.1016/j.ccr.2024.216299 ↗
38. Feng Y, Qi S, Yu X, et al. Supramolecular modulation of tumor microenvironment through pillar[5]arene-based host–guest recognition to synergize cancer immunotherapy. J Am Chem Soc, 2023, 145: 18789–1879910.1021/jacs.3c03031 ↗
39. Zhu H, Wang H, Shi B, et al. Supramolecular peptide constructed by molecular Lego allowing programmable self-assembly for photodynamic therapy. Nat Commun, 2019, 10: 241210.1038/s41467-019-10385-9 ↗
40. Wu MX, Yan HJ, Gao J, et al. Multifunctional supramolecular materials constructed from polypyrrole@UiO-66 nanohybrids and pillararene nanovalves for targeted chemophotothermal therapy. ACS Appl Mater Interfaces, 2018, 10: 34655–3466310.1021/acsami.8b13758 ↗
41. Lu B, Xia J, Huang Y, et al. The design strategy for pillararene based active targeted drug delivery systems. Chem Commun, 2023, 59: 12091–1209910.1039/D3CC04021F ↗
42. Yu G, Yu W, Shao L, et al. Fabrication of a targeted drug delivery system from a pillar[5]arene-based supramolecular diblock copolymeric amphiphile for effective cancer therapy. Adv Funct Mater, 2016, 26: 8999–900810.1002/adfm.201601770 ↗
43. Wei P, Czaplewska JA, Wang L, et al. Straightforward access to glycosylated, acid sensitive nanogels by host–guest interactions with sugar-modified pillar[5]arenes. ACS Macro Lett, 2020, 9: 540–54510.1021/acsmacrolett.0c00030 ↗
44. Li J, Lv X, Li J, et al. A supramolecular near-infrared nanophoto-sensitizer from host-guest complex of lactose-capped pillar[5]arene with aza-BODIPY derivative for tumor eradication. Org Chem Front, 2023, 10: 1927–193510.1039/D3QO00065F ↗
45. Li D, Chen X, Dai W, et al. Photo-triggered cascade therapy: a NIR-II AIE luminogen collaborating with nitric oxide facilitates efficient collagen depletion for boosting pancreatic cancer phototheranostics. Adv Mater, 2024, 36: 230647610.1002/adma.202306476 ↗